These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 29328401)
1. Long non-coding RNA MEG3 functions as a tumour suppressor and has prognostic predictive value in human pancreatic cancer. Ma L; Wang F; Du C; Zhang Z; Guo H; Xie X; Gao H; Zhuang Y; Kornmann M; Gao H; Tian X; Yang Y Oncol Rep; 2018 Mar; 39(3):1132-1140. PubMed ID: 29328401 [TBL] [Abstract][Full Text] [Related]
2. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway. Xu F; Huang M; Chen Q; Niu Y; Hu Y; Hu P; Chen D; He C; Huang K; Zeng Z; Tang J; Wang F; Zhao Y; Wang C; Zhao G Cancer Res; 2021 Nov; 81(22):5678-5691. PubMed ID: 34593522 [TBL] [Abstract][Full Text] [Related]
3. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer. Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599 [TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells. Li H; Wang P; Liu J; Liu W; Wu X; Ding J; Kang J; Li J; Lu J; Pan G J Clin Lab Anal; 2020 Sep; 34(9):e23369. PubMed ID: 32618397 [TBL] [Abstract][Full Text] [Related]
5. ENO1 contributes to the gemcitabine resistance of pancreatic cancer through the YAP1 signaling pathway. Ma H; Kong L; Liu L; Du Y; Zhu X; Wang J; Zhao W Mol Carcinog; 2024 Jul; 63(7):1221-1234. PubMed ID: 38517039 [TBL] [Abstract][Full Text] [Related]
6. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205. Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008 [TBL] [Abstract][Full Text] [Related]
7. Resistance to gemcitabine is mediated by the circ_0036627/miR-145/S100A16 axis in pancreatic cancer. Yu S; Wang M; Zhang H; Guo X; Qin R J Cell Mol Med; 2024 Jun; 28(12):e18444. PubMed ID: 38924205 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-200b and -301 are associated with gemcitabine response as biomarkers in pancreatic carcinoma cells. Funamizu N; Lacy CR; Kamada M; Yanaga K; Manome Y Int J Oncol; 2019 Mar; 54(3):991-1000. PubMed ID: 30628651 [TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. Li Z; Zhao X; Zhou Y; Liu Y; Zhou Q; Ye H; Wang Y; Zeng J; Song Y; Gao W; Zheng S; Zhuang B; Chen H; Li W; Li H; Li H; Fu Z; Chen R J Transl Med; 2015 Mar; 13():84. PubMed ID: 25889214 [TBL] [Abstract][Full Text] [Related]
10. A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2. Yang S; He P; Wang J; Schetter A; Tang W; Funamizu N; Yanaga K; Uwagawa T; Satoskar AR; Gaedcke J; Bernhardt M; Ghadimi BM; Gaida MM; Bergmann F; Werner J; Ried T; Hanna N; Alexander HR; Hussain SP Cancer Res; 2016 Jul; 76(13):3838-50. PubMed ID: 27197190 [TBL] [Abstract][Full Text] [Related]
11. Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells. Xiong Y; Wang J; Zhu H; Liu L; Jiang Y Oncol Rep; 2018 Mar; 39(3):967-976. PubMed ID: 29328404 [TBL] [Abstract][Full Text] [Related]
12. miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn. Liu G; Ji L; Ke M; Ou Z; Tang N; Li Y Biomed Pharmacother; 2018 Oct; 106():523-531. PubMed ID: 29990840 [TBL] [Abstract][Full Text] [Related]
13. miR-153 enhances the therapeutic effect of gemcitabine by targeting Snail in pancreatic cancer. Liu F; Liu B; Qian J; Wu G; Li J; Ma Z Acta Biochim Biophys Sin (Shanghai); 2017 Jun; 49(6):520-529. PubMed ID: 28459992 [TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG8 promotes the development and chemo-resistance of pancreatic adenocarcinoma. Song Y; Zou L; Li J; Shen ZP; Cai YL; Wu XD Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8161-8168. PubMed ID: 30556854 [TBL] [Abstract][Full Text] [Related]
15. MiRNA-145 increases therapeutic sensibility to gemcitabine treatment of pancreatic adenocarcinoma cells. Lin Y; Ge X; Wen Y; Shi ZM; Chen QD; Wang M; Liu LZ; Jiang BH; Lu Y Oncotarget; 2016 Oct; 7(43):70857-70868. PubMed ID: 27765914 [TBL] [Abstract][Full Text] [Related]
16. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma. Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893 [TBL] [Abstract][Full Text] [Related]
17. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro. Xu J; Liu S; Yang X; Cao S; Zhou Y Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386 [TBL] [Abstract][Full Text] [Related]
18. Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207. You L; Wang H; Yang G; Zhao F; Zhang J; Liu Z; Zhang T; Liang Z; Liu C; Zhao Y Mol Oncol; 2018 Dec; 12(12):2147-2164. PubMed ID: 30341811 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of MBD1 promotes pancreatic cancer cell epithelial-mesenchymal transition and invasion by epigenetic down-regulation of E-cadherin. Xu J; Zhu W; Xu W; Yao W; Zhang B; Xu Y; Ji S; Liu C; Long J; Ni Q; Yu X Curr Mol Med; 2013 Mar; 13(3):387-400. PubMed ID: 23331011 [TBL] [Abstract][Full Text] [Related]
20. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Bao B; Wang Z; Ali S; Ahmad A; Azmi AS; Sarkar SH; Banerjee S; Kong D; Li Y; Thakur S; Sarkar FH Cancer Prev Res (Phila); 2012 Mar; 5(3):355-64. PubMed ID: 22086681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]